Former Chairman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Former Chairman
Former Chairman is recorded as CEO at Harvard Bioscience Inc (HBIO). The proxy statement of Harvard Bioscience Inc reports total compensation of $2,336,576 for Former Chairman in fiscal 2024, including a base salary of $513,431.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harvard Bioscience Inc
Other people whose current roles at this company are on record from its filings.
- John Duke CEO, Board Member
- Katherine Eade Chairman
- Mark Frost CFO
- Kenneth Olson COO
- Bertrand Loy Board Member
- Bill Snider Board Member
- John D. Duke Board Member
- Katherine A. Eade Board Member
- Mr. William A. Snider Board Member
- Rob Gagnon Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Harvard Bioscience Inc (HBIO) | President & Chief Executive Officer | $513,431 | $2,336,576 |
Recent activity
No call appearances or filed executive changes recorded yet.